AEON Biopharma (AEON) via Priveterra Acq (PMGM) deck

AEON is a clinical stage biopharmaceutical company focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions with an initial focus on the neurology and gastroenterology markets.

Debarshi Ghosh

This post is for subscribers only

Subscribe

Already have an account? Log in

You might also like

Clearday via Viveon Health Acq (VHAQ) deck Members Public

Clearday™ is an innovative longevity healthcare technology company with a modern, hopeful vision for making high-quality care solutions more accessible, affordable, and empowering for aging individuals and their families.

Debarshi Ghosh
Healthcare

Sakuu (SAKU) via Plum Acq Corp. I (PLMI) deck Members Public

Sakuu is the inventor of high-volume multi-material, multi-process Kavian™ additive manufacturing platforms to produce SwiftPrint™ batteries and other complex active devices.

Debarshi Ghosh
Technology

Featured Posts

Triple Good News

Heidmar looks good for a company in shipping.

MoneyLion Mirage

Authors →

Debarshi Ghosh

Kris Tuttle

Developed AI (OPS) applications at CMU and then IBM in the 80's and 90's. Went to Wall Street with an MBA in Finance. Retired in 2004 to focus on independent investment research and active investing.